Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis

World Journal of Gastroenterology

Volumn 11, Issue 34, 2005, Pages 5303-5308

  Polese, Lino ^a,b   Angriman, Imerio ^a   De Franchis, Giuseppe ^a   Cecchetto, Attilio ^a   Sturniolo, Giacomo C ^a   D'Incà, Renata ^a   Scarpa, Marco ^a   Ruffolo, Cesare ^a   Norberto, Lorenzo ^a   Frego, Mauro ^a   D'Amico, Davide F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Arthritis; CD40; CD40L; Pouchitis; Spondyloarthropathy; Ulcerative colitis

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON MUCOSA; COLON POUCH; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MONOCYTE; PATHOGENESIS; PROCTOCOLECTOMY; PROTEIN FUNCTION; SPONDYLOARTHROPATHY; ULCERATIVE COLITIS;

EID: 26244432419     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i34.5303     Document Type: Article

References (35)

1. Radford-Smith G. Ulcerative colitis: an immunological disease? Baillière's Clinical Gastroenterol 1997; 11: 35-52
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
3. Lavery IC, Sirimarco MT, Ziv Y, Fazio VW. Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum 1995; 38: 803-806
4. Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, Hurst RD. Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis A prospective observational study. Ann Surg 2003; 238: 433-445
5. Scarpa M, Angriman I, Ruffolo C, Ferronato A, Polese L, Barollo M, Martin A, Sturniolo GC, D'Amico DF. Health related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results. World J Surg 2004; 28: 124-129
6. Nicholls RJ, Banerjee MS. Pouchitis: risk factors, etiology and treatment. World J Surg 1998; 22: 347-351
7. Stocchi L, Pemberton JH. Pouch and pouchitis. Gastroenterol Clin North Am 2001; 30: 223-241
8. Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000; 24: 851-856
9. Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Lofberg R. Pouchitis following pelvic pouch operation for ulcerative colitis: Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39: 1012
10. Gramlich T, Delaney CP, Lynch AC, Remzi FH, Fazio VW. Pathological subgroups may predict complications but not late failure after ileal pouch-anal anastomosis for indeterminate colitis. Colorect Dis 2003; 5: 315-319
11. Patel RT, Bain I, Youngs D, Keighley MR. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995; 38: 831-837
12. Stallmach A, Schafer F, Hoffmann S, Weber S, Muller-Molaian I, Schenider T, Kohne G, Ecker KW, Feifel G, Zeitz M. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut 1998; 43: 499
13. Stallmach A, van Look M, Scheiffele F, Ecker KW, Feifel G, Duchmann R, Zeitz M. IgG, albumin, and sCD44 in whole-gut lavage fluid are useful clinical markers for assessing the presence and activity of pouchits. Int J Colorect Dis 1999; 14: 35
14. Van Kooten C, Banchereau J. Functional role of CD40 and ist ligand. Int Arch Allergy Immunol 1997; 113: 393-399
15. Polese L, Angriman I, Cecchetto A, Norberto L, Scarpa M, Ruffolo C, Barollo M, Sommariva A, D'Amico DF. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol 2002; 14: 237-241
16. Liu Z, Colpaert S, D'Haens GR, Kasran A, de Boer M, Rutgeerts P, Geboes K, Ceuppens JL. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 1999; 163: 4049-4057
17. Battaglia E, Biancone L, Resegotti A, Emanuelli G, Fronda GR, Camussi G. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am J Gastroenterol 1999; 94: 3279-3284
18. Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y. An increased number of CD40-high monocytes in patients with Crohn's disease. Am J Gastroenterol 2000; 95: 1516-1523
19. Vogel JD, West GA, Danese S, De La Motte C, Philipps MH, Strong SA, Willis J, Fiocchi C. CD40 mediated immune-nonimmune cells interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. Gastroenterology 2004; 126: 63-80
20. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: pouchitis activity index. Mayo Clinic Proc 1994; 69: 409-415
21. Dougados M, Van der Linden S, Juhin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G. The European Spondyloarthropaty Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991; 34: 1218-1227
22. Seo M, Okada M, Yao T, Ueki M, Arima S, Okomura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-976
23. Baron JH, Connel AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1: 89-92
24. Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ilal pouch-anal anastomosis. Ann Surg 1990; 211: 622-627
25. Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scan J Gastroenterol 2003; 38: 1055-1058
26. Thomas PD, Keat AC, Forbes A, Ciclitira PJ, Nicholls RJ. Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy. Eur J Gastroenterol Hepatol 1999; 11: 1001-1005
27. Kuhbacher T, Schreiber S, Runkel N. Pouchitis: pathophysiology and treatment. Int J Colorect Dis 1998; 13: 196-207
28. Schmidt CM, Lanzeby AJ, Hendrickson RJ, Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654-665
29. Gustavsson S, Weiland LH, Kelly KA. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anala anastomosis. Dis Colon Rectum 1987; 30: 25-28
30. Polese L, Keighley MRB. Adenomas at resection margins do not influence the long-term development of pouch polyps after restorative proctocolectomy for familial adenomatous polyposis. Am J Surg 2003; 186: 32-34
31. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52: 1435-1441
32. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994; 152: 2613-2623
33. Rissoan MC, Van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, Miossec P, Banchereau J. The functional CD40 antigen of fibroblast may contribute to proliferation of rheumatoid synovium. Clin Exp Immunol 1996; 104: 481-490
34. Sekine C, Yagita H, Miyasaka N, Okomura K. Expression and function of CD40 in rheumatoid arthritis synovium. J Rheumatoid 1998; 25: 1048-1053
35. Kyburtz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA. Human rheumatoid factor production is dependent on CD40 signaling and autoantigens. J Immunol 1999; 163: 3116-3122